A detailed history of Acuitas Investments, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Acuitas Investments, LLC holds 69,175 shares of FLGT stock, worth $1.23 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
69,175
Previous 49,016 41.13%
Holding current value
$1.23 Million
Previous $961,000 56.3%
% of portfolio
0.72%
Previous 0.54%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$19.6 - $25.06 $395,116 - $505,184
20,159 Added 41.13%
69,175 $1.5 Million
Q2 2024

Aug 05, 2024

BUY
$19.09 - $22.57 $935,715 - $1.11 Million
49,016 New
49,016 $961,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $538M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Acuitas Investments, LLC Portfolio

Follow Acuitas Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuitas Investments, LLC with notifications on news.